CHU YU-WAYE (Chief Medical Officer) received a stock award from CYTOMX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2026ACC: 0001610717-26-000042
Officer· Chief Medical Officer
Since Feb 2026
+375K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
375K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
55.3%
2/2/2026
135.72K→210.72K
Total
Net shares
+75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +75K | — | — | 55.3% | 135.72K | 210.72K |
| Total | +75K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
300K shares
Shares
+300K
Strike price
6.09
Held after
300K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock300K shares | 2/2/2026 | A · Award | +300K | 6.09 | — | 300K |